Articles tagged with Cancer Patients
Researchers collected three tumor samples from a patient with salivary gland cancer, revealing a significant increase in cancer stem cells and aggressive mutations over time. This study demonstrates how tumors can adapt and overcome therapies, leading to relapse and treatment resistance.
A new study by NYU Langone Health reveals that patients from lower-income areas have a significantly reduced chance of surviving anal cancer. The research, led by Dr. Daniel Becker, found a strong association between median household income and overall survival rates.
Researchers established two new adrenal cancer cell lines and mouse models to test novel treatments, identifying PBK as a key target. A patient treated with pembrolizumab showed remarkable response with 77% tumor reduction, while a humanized mouse model also responded to the immunotherapy.
Researchers found that elevated methylglyoxal levels lead to insulin resistance, obesity, and high blood sugar levels in flies, challenging the conventional view of type 2 diabetes. This discovery raises questions about the molecular causes of the disease.
Patients with urological cancers, such as prostate and bladder cancer, are five times more likely to commit suicide than the general population. The study found that severe psychological stress is a major side-effect of cancer diagnosis and treatment, leading to higher rates of depression, PTSD, and suicidal intent in this patient group.
Researchers developed a new molecular classification method using DNA methylation patterns to differentiate 82 types of CNS tumors. The method improved diagnostic accuracy in some cases, with over 12% of cases corrected after analysis.
A major international survey found that around 25% of patients with penile cancer are not receiving recommended treatment. This leads to a significantly lower survival rate, with twice as many patients surviving if treated according to guidelines.
The non-profit organization Destroy Pancreatic Cancer is funding a new clinical trial designed by Dr. Daniel D. Von Hoff at the Piedmont Cancer Institute, aiming to improve treatment options for pancreatic cancer patients. The trial will enroll up to 25 patients and is part of TGen's efforts to find a cure for this deadly disease.
Research at Huntsman Cancer Institute found that estrogen and glucocorticoid receptors work together to promote more aggressive endometrial cancers. The study suggests that corticosteroids, a stress hormone, can make the uterine lining stop growing but may also contribute to tumor growth when combined with high estrogen levels.
A study published in CANCER found that living in low-income areas increases the risk of early death among patients with anal cancer. The researchers analyzed data from 9,550 patients and found that those in lower income areas had worse overall survival and cancer-specific survival compared to those in higher income areas.
A recent study found that patients are willing to travel up to 75 minutes longer and 5 hours longer to receive specialized cancer care with improved outcomes. Centralization of cancer surgery services can reduce variations in quality of care and improve patient health outcomes.
Research from the University of Pittsburgh School of Medicine discovered that preventing T-cell exhaustion with targeted therapies enhances immunotherapy outcomes. Activating a protein called 41BB on the surface of T-cells improves energy reserves and prolongs their ability to attack cancer cells.
Research reveals that breast cancer and lymphoma patients are at increased risk of developing congestive heart failure, with a threefold higher risk compared to non-cancer patients. Periodic cardiac imaging and lifestyle changes may help mitigate this risk.
Researchers from DKFZ found that circulating cancer cells exhibit specific polarity, which helps them attach to endothelial cells and migrate into tissues. This discovery may help predict individual risk for metastasis and find therapies to reduce it.
A comprehensive genomic analysis of childhood cancer reveals that children and adults have different mutated genes driving their disease, underscoring the need for pediatric-specific precision therapies. The study found that only 45% of the mutated genes 'driving' cancer in children are the same as those in adults.
Researchers found that patients with a history of breast cancer or lymphoma are three times more likely to develop heart failure than those without cancer. Elevated risks were associated with diabetes, high doses of chemotherapy, and anthracycline drugs.
A new study from St. Jude Children's Research Hospital and the American University of Beirut Medical Center demonstrates effective childhood cancer treatment in a refugee setting. The institution adapted its services to prioritize curable cases, showcasing a viable model for crisis response.
A combined analysis of family history and genetic markers improves risk prediction for colorectal cancer, revealing that individuals with a positive family history and numerous genetic variants are at increased risk. This approach can help adjust preventive measures and screening schedules.
Researchers will study basal-squamous and luminal subtypes of aggressive bladder cancer using a mouse model and human cancer cell lines. Understanding the role of TFAP2 transcription factors may lead to new therapeutic approaches for predicting patient response to treatment.
In three clinical trials, larotrectinib demonstrated a 75% overall response rate in patients with TRK fusion genes, with 86% continuing treatment or undergoing curative surgery. This study marks a new paradigm in cancer drug development, defining cancers by molecular changes rather than site of occurrence.
Researchers have developed a novel compound targeting STAT5, which selectively disrupts its activation and gene transcription, impairing AML cell proliferation. The compound showed efficacy in patient-derived AML cell lines and freshly isolated patient samples, indicating its potential as a new treatment option for leukemia.
A phase I clinical trial has shown some promise for an investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers. Three patients experienced partial responses to the treatment, similar to response rates seen with other treatments such as MEK inhibitors.
The studies reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. Larotrectinib had rapid, potent, and durable anti-tumor activity in children and adults with solid tumors and TRK fusions.
A phase 1/2 trial of larotrectinib found that three-quarters of patients with advanced cancers responded to the treatment, which targets a specific genetic mutation. The therapy has shown promise in treating pediatric patients with TRK-positive cancer, including infantile fibrosarcoma, and offers a potential cure for some cases.
Researchers developed a method combining diffusion-weighted MRI with intelligent image analysis to detect malignant changes in breast tissue. The new method reduced false positive findings by 70% and accurately identified malignant tumors in 98% of cases.
A study found that patients with advanced cancer were less capable of making treatment decisions than healthy adults, but doctors often overestimated their competence. The research suggests a shift in patient-doctor relationships, emphasizing the importance of respecting patient autonomy while ensuring decision-making capacity.
Researchers developed a liquid biopsy test to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer. The study found that 64% of patients had more than 10% tumor DNA, correlated with poor survival outcomes.
A new study published in JAMA Surgery found that breast cancer patients who undergo mastectomy with or without immediate reconstruction tend to be less satisfied than expected with their physical and sexual health post-surgery. Women who choose immediate reconstruction overestimated their satisfaction with appearance, while those who d...
Researchers have identified a unique packaging method of genes in early embryos that helps regulate their expression. This study provides insights into the mechanisms controlling embryonic development, which may impact gene expression and inheritance, including predisposition to diseases like cancer.
Scientists have discovered that the Huntington's gene is toxic to cancer cells due to its repetitive RNA sequences, which can be harnessed for a novel cancer treatment approach. Researchers hope to develop a short-term treatment to kill cancer cells without causing neurological issues associated with Huntington's disease.
Researchers at Cold Spring Harbor Laboratory have discovered that a widely-studied cancer gene called MELK does not play a crucial role in cancer cell growth. The team's findings suggest that inherent flaws in scientific techniques used to link MELK to cancer led to the error.
A study combining axitinib and pembrolizumab found the treatment to be tolerable and doubling efficacy in patients with advanced kidney cancer. Over 90% of patients exhibited tumor shrinkage, keeping disease under control for over 20 months.
Teleconsulting is crucial for rare cancers like sarcomas, which require specialized expertise. EURACAN, a European Reference Network, aims to provide timely diagnosis and treatment through referral networks.
A new hybrid-capture sequencing assay has been established as the method of choice for detecting 'actionable' gene mutations in lymphoid cancer, with a high accuracy rate of 91%. The assay can be implemented by clinical laboratories into routine diagnostic workflows.
Research from the Francis Crick Institute discovered that immune cells called Natural Killer cells accumulate in tumours and release chemicals attracting specialised dendritic cells. Genes associated with these cells correlated with cancer patient survival rates, suggesting a new basis for immunotherapies.
Scientists have successfully grown human eggs in a laboratory from their earliest stage to full maturity, paving the way for improved fertility treatments. The advance aims to safeguard the fertility of girls with cancer ahead of potentially harmful medical treatment.
One hundred high school students from 28 states have been named winners in the third year of PBS' and Stand Up To Cancer's Emperor Science Award program. The recipients will work with a university scientist on a multi-week cancer research project, receive a Google Chromebook computer, and a $1,500 stipend.
The marbled crayfish, a single female ancestor of all Marmorkrebs specimens, exhibits epigenetic mechanisms that enable rapid adaptation to various environments without genetic variation. This clonal genome evolution shares similarities with tumor development, where environmental factors influence gene regulation and adaptation.
Researchers identified unique mitochondrial defects and alterations in metabolic gene expression associated with aggressive triple-negative breast cancers. The findings provide new molecular biomarkers to identify patients at risk for metastasis and offer potential therapeutic targets.
Researchers Jos Jonkers and Helen Piwnica-Worms receive a grant to investigate how the immune system recognizes breast cancer. They will use imaging mass cytometry and patient-derived models to devise new treatment combinations, accelerating promising therapies to patients.
Exercising regularly before surgery for lung cancer halves the complication rate afterwards, with a 48% reduction in postoperative complications. Exercise also reduces the length of hospital stay by almost three days, according to a pooled analysis of 13 clinical trials involving 806 participants.
Researchers at UT Southwestern's Simmons Cancer Center have made a historic breakthrough in CAR-T therapy for acute lymphoblastic leukemia (ALL) in children and young adults. Eighty-one percent of patients treated with CAR-T therapy went into remission, offering new hope for those previously untreatable.
A new web-based stress management program has been shown to significantly improve the quality of life and reduce distress in newly diagnosed cancer patients. The online program, developed by researchers from the University of Basel, provides patients with information, exercises, and strategies to manage their condition.
Seven multi-disciplinary teams will investigate immune system response to cancers, exploring factors such as DNA mismatch repair, tumor-specific proteins, and cytokine function. The teams will use machine learning expertise and access to terabytes of data to develop new treatments with less damage.
The CONCORD-3 study reveals global improvement in cancer survival, with some countries experiencing significant gains, while others lag behind. However, disparities in childhood cancers and incomplete data in Africa limit the accuracy of these findings.
A recent study presented at the American Stroke Association's International Stroke Conference found that cancer patients with stroke are less likely to receive standard clot-busting medication compared to those without a malignancy. The use of newer procedures to mechanically remove clots, however, shows a similar trend in both groups.
A new study provides guidelines for assessing the severity of head and neck cancers by counting malignant lymph nodes, which are found to be a key factor in predicting patient survival. The number of positive nodes can categorize patients into distinct groups with varying outcomes.
The foundation awarded grants to early career scientists with 'high-risk/high-reward' ideas who lack preliminary data, aiming to significantly impact cancer prevention, diagnosis, and treatment. The recipients will use prebiotics to manipulate the microbiota, develop novel degraders for targeted therapies, and investigate tumor T cells...
Researchers found that even mild depressive symptoms were associated with poorer overall survival in patients with head and neck cancer. The study indicates that patients should be screened for depressive symptoms at diagnosis and treated promptly to improve treatment outcomes.
The VTX-1 Liquid Biopsy System is a commercial, automated instrument that isolates clinically relevant CTC populations directly from whole blood. It achieves high recovery rates of spiked breast and lung cancer cell lines, with purities as low as <100 white blood cells per mL of processed blood.
A study found that pediatric cancer patients' microbiome diversity can predict the risk of developing blood infections, suggesting a link between gut health and bloodstream infections. The researchers argue that prevention and treatment strategies may depend on the source of infection, rather than relying solely on central line hygiene.
A University of Colorado Cancer Center study found low post-treatment mortality rates for both surgery and targeted radiation in early-stage lung cancer patients. Patients over 80 years old showed significantly higher mortality rates with surgery compared to targeted radiation.
A long-term health study found a 24% increase in cancer risk among participants with severe periodontitis compared to those with mild to no periodontitis. The highest risk was observed in cases of lung cancer, followed by colorectal cancer.
A new mathematical tool, based on Bayes' Theorem, was developed to validate and improve methods for interpreting clinical genetic test results. The tool assessed the rigor of widely-used approaches and found that a system of 18 rules is statistically sound and objectively strong.
Researchers developed CancerSEEK, a noninvasive blood test detecting cancer mutations and protein biomarkers in the blood. The test detected cancer with a sensitivity of 69-98% and was 99% specific.
Researchers have identified a new precision medicine approach for metastatic pancreatic cancer, analyzing tumor RNA to match patients with targeted drugs. The approach has shown clinical responses in three of four patients, targeting 'master regulator proteins' responsible for cancer cell survival.
A new review examines the quality-of-life consequences of genetic testing and risk-reducing surgery, finding that procedures can decrease cancer anxiety but are associated with short- and long-term complications.
A Mayo Clinic study published in the New England Journal of Medicine found that patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer even after 30 years. The overall risk of progression is relatively small, but it persists indefinitely.
3D organoid models derived from patient cells can guide clinical decision-making for individuals with gastrointestinal cancers. Researchers hope these models will predict treatment response and increase response rates by finding the best treatment combination for every patient.
A gene enhancer cluster, BENC, plays a crucial role in regulating Myc activity and cancer growth. The discovery suggests BENC as a potential target for novel therapies against blood cancer.